Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial (Q43955548)

28 November 2017

Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial (English)

1 reference

multicenter clinical trial

28 November 2017

0 references

1 reference

1 reference

1 reference

Giangennaro Coppola

1

1 reference

28 November 2017

Giuseppe Capovilla

2

1 reference

28 November 2017

Alessandra Montagnini

3

1 reference

28 November 2017

Antonino Romeo

4

1 reference

28 November 2017

Maria Spanò

5

1 reference

28 November 2017

Gaetano Tortorella

6

1 reference

28 November 2017

Pierangelo Veggiotti

7

1 reference

28 November 2017

Maurizio Viri

8

1 reference

28 November 2017

Antonio Pascotto

9

1 reference

28 November 2017

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

49

1 reference

28 November 2017

1

1 reference

28 November 2017

45-48

1 reference

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

Topiramate in intractable childhood onset epilepsy--a cautionary note

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

A pilot study of topiramate in the treatment of infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

Neurotrophin-3 levels in cerebrospinal fluid from children with bacterial meningitis, viral meningitis, or encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

Topiramate for intractable childhood epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

Topiramate in the treatment of severe myoclonic epilepsy in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

Clinical experiences with topiramate in children with intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

Paroxysmal tonic upgaze: physiopathological considerations in three additional cases

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

Topiramate for drug-resistant epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900010-4

7 January 2021

10.1016/S0920-1211(02)00010-4

Identifiers

DOI

1 reference

28 November 2017

1 reference